Are there Gender Specific Differences in Patient Characteristics at Initiation of Biologic Treatment in Rheumatoid Arthritis?

被引：0
|
作者：
Bensen, William [1 ]
Choquette, Denis [2 ]
Fortin, Isabelle [3 ]
Klinkhoff, Alice [4 ]
Rampalcakis, Emmanouil [5 ,6 ]
Sampalis, John [7 ,8 ]
Shawi, May [9 ]
Lehman, Allen [9 ]
Otawa, Susan [9 ]
机构：
[1] McMaster Univ, St Josephs Hosp, Rheumatol Hlth Team, Hamilton, ON L8S 4L8, Canada
[2] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada
[3] Ctr Sante & Serv Sociaux Rimousk, Rimouski, PQ, Canada
[4] Mary Pack Arthrit Program, Vancouver, BC, Canada
[5] JSS Med Res, St Laurent, PQ, Canada
[6] McGill Univ, St Laurent, PQ, Canada
[7] McGill Univ, Westmount, PQ, Canada
[8] Univ Montreal, Westmount, PQ, Canada
[9] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
187
引用
收藏
页码：1020 / 1021
页数：2
相关论文
共 50 条
  • [21] Variability In Patient Characteristics and Outcomes In Rheumatoid Arthritis Upon Infliximab Treatment Based On The Size Of Biologic Treatment Registry Site
    Thorne, J. Carter
    Bensen, William G.
    Dixit, Sanjay
    Faraawi, Rafat Y.
    Sholter, Dalton E.
    Sheriff, Maqbool K.
    Baer, Philip
    Choquette, Denis
    Haraoui, Boulos
    Jovaisas, Algis
    Rampakakis, Emmanouil
    Sampalis, John S.
    Shawi, May
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan M.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1019 - S1020
  • [22] Patient Preferences for Biologic Treatments in Rheumatoid Arthritis
    Nafees, Beenish
    Lloyd, Andrew
    Gaich, Carol L.
    Birt, Julie
    Hughes, Rodney A.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S213 - S213
  • [23] The Effect of Patient, Prescriber and Region on the Initiation of First Biologic for Rheumatoid Arthritis: A Longitudinal Population Study
    Tatangelo, Mark
    Tomlinson, George A.
    Paterson, Michael
    Bansback, Nick
    Gomes, Tara
    Kopp, Alex
    Ahluwalia, Vandana
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] PATIENT OUTCOMES ASSOCIATED WITH BIOLOGIC INFUSION SITE OF CARE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Bolge, S.
    Ingham, M.
    Gupta, S.
    VALUE IN HEALTH, 2011, 14 (03) : A134 - A134
  • [25] Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective
    Bolge, Susan C.
    Goren, Amir
    Tandon, Neeta
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 121 - 131
  • [26] Patient Characteristics, Treatment Patterns, and Treatment Persistency in Biologic DMARD-Experienced Rheumatoid Arthritis Patients in a US RA Registry
    Dore, Robin
    Antonova, Jenya
    Harrold, Leslie
    Chang, Lawrence
    Scherer, Emily
    Cronin, Angel
    Emeanuru, Kelechi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] PATIENT CHARACTERISTICS AND REASONS FOR BIOLOGIC MONOTHERAPY IN EU5 MARKETS IN RHEUMATOID ARTHRITIS
    Sullivan, E.
    Kershaw, J.
    Blackburn, S.
    Mahajan, P.
    Boklage, S.
    VALUE IN HEALTH, 2017, 20 (09) : A539 - A539
  • [28] Emerging biologic drugs for the treatment of rheumatoid arthritis
    Puppo, F
    Murdaca, G
    Ghio, M
    Indiveri, F
    AUTOIMMUNITY REVIEWS, 2005, 4 (08) : 537 - 541
  • [29] The Use of Biologic Therapies in the Treatment of Rheumatoid Arthritis
    Wang, Dashan
    Li, Yan
    Liu, Yuan
    Shi, Guixiu
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (06) : 542 - 548
  • [30] Novel biologic approaches to the treatment of rheumatoid arthritis
    Sany, J
    REVUE DU RHUMATISME, 1999, 66 (11): : 548 - 559
12345